These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42 related articles for article (PubMed ID: 21780970)
1. Ranulas: possible signs for HIV/AIDS? 1 year Ugandan descriptive study. Kamulegeya A; Okello SM Acta Odontol Scand; 2012 Mar; 70(2):149-53. PubMed ID: 21780970 [TBL] [Abstract][Full Text] [Related]
2. Quantification of HIV-1 viral load in the fluid of ranulas in HIV-positive patients. Syebele K; Bütow KW; Webber L; Manda SO Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jun; 111(6):715-9. PubMed ID: 21569988 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western India. Shah SU; Kerkar SP; Pazare AR Br J Ophthalmol; 2009 Jan; 93(1):88-90. PubMed ID: 18952644 [TBL] [Abstract][Full Text] [Related]
4. Oral mucoceles and ranulas may be part of initial manifestations of HIV infection. Syebele K; Bütow KW AIDS Res Hum Retroviruses; 2010 Oct; 26(10):1075-8. PubMed ID: 20860533 [TBL] [Abstract][Full Text] [Related]
5. Oral mucocele/ranula: Another human immunodeficiency virus-related salivary gland disease? Syebele K; Munzhelele TI Laryngoscope; 2015 May; 125(5):1130-6. PubMed ID: 25446909 [TBL] [Abstract][Full Text] [Related]
6. Ranula: experience with 83 cases in Zimbabwe. Chidzonga MM; Mahomva L J Oral Maxillofac Surg; 2007 Jan; 65(1):79-82. PubMed ID: 17174768 [TBL] [Abstract][Full Text] [Related]
7. Ranula: another HIV/AIDS associated oral lesion in Zimbabwe? Chidzonga MM; Rusakaniko S Oral Dis; 2004 Jul; 10(4):229-32. PubMed ID: 15196145 [TBL] [Abstract][Full Text] [Related]
8. Patterns of skin manifestations and their relationships with CD4 counts among HIV/AIDS patients in Cameroon. Josephine M; Issac E; George A; Ngole M; Albert SE Int J Dermatol; 2006 Mar; 45(3):280-4. PubMed ID: 16533229 [TBL] [Abstract][Full Text] [Related]
9. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002. Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P; HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287 [TBL] [Abstract][Full Text] [Related]
10. Impact of baseline CD4(+) T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study. Liu ZY; Guo FP; Han Y; Qiu ZF; Zuo LY; Li YL; Li TS Chin Med J (Engl); 2009 Oct; 122(20):2497-502. PubMed ID: 20079166 [TBL] [Abstract][Full Text] [Related]
11. Antiretroviral Service to HIV patients of low CD4 count in Seti Zonal Hospital. Paudel BN; Chaudhary SR; Sharma S; Dhungana GP; Paudel P JNMA J Nepal Med Assoc; 2009; 48(173):24-7. PubMed ID: 19529054 [TBL] [Abstract][Full Text] [Related]
12. Brazilian HIV-infected population: assessment of the needs of endodontic treatment in the post-highly active antiretroviral therapy era. de Brito LC; da Rosa MA; Lopes VS; e Ferreira EF; Vieira LQ; Sobrinho AP J Endod; 2009 Sep; 35(9):1178-81. PubMed ID: 19720212 [TBL] [Abstract][Full Text] [Related]
13. Clinical manifestations of treatment-naive patients with acquired immunodeficiency syndrome and responses to highly active antiretroviral therapy in the Taipei Veterans General Hospital: a 5-year prospective study. Hsu SF; Yang SP; Chan YJ; Wang YW J Microbiol Immunol Infect; 2011 Jun; 44(3):198-203. PubMed ID: 21524614 [TBL] [Abstract][Full Text] [Related]
15. [Study on the association of clinical characteristic, CD4+ and level of HIV viral load among 690 initial HIV-infection]. Liu YC; Li XH; Li XW; Lun WH; Yan HW; Ge ML; Zhu XJ Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):1026-9. PubMed ID: 18399155 [TBL] [Abstract][Full Text] [Related]
16. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death. Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD; HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766 [TBL] [Abstract][Full Text] [Related]
17. [Detection of the viral load and its use as a virological marker in the follow-up of HIV-1-positive patients]. Hodara VL; Monticelli A; Benetucci J; Lasala M; Jauregui Rueda H; Libonatti O; García Messina O; Reboredo G; Bogdanowicz E; Bases O; Pampuro S; Salomón H Rev Argent Microbiol; 1998; 30(1):1-7. PubMed ID: 9629601 [TBL] [Abstract][Full Text] [Related]
18. Circulating Epstein-Barr virus (EBV) in HIV-infected patients and its relation with primary brain lymphoma. Fellner MD; Durand K; Correa RM; Redini L; Yampolsky C; Colobraro A; Sevlever G; Teyssié AR; Benetucci J; Picconi MA Int J Infect Dis; 2007 Mar; 11(2):172-8. PubMed ID: 16931088 [TBL] [Abstract][Full Text] [Related]
19. [The prognostic markers of survival and progression in HIV-1 infection. A study of CD4+ lymphocytes, antigen p24 and viral load during 3 years in a cohort of 251 patients]. Rubio Caballero M; Nogués Biau A; Falguera Sacrest M; Puig Ganau T; Lecha N; Rubio Rivas C An Med Interna; 2000 Oct; 17(10):533-7. PubMed ID: 11109648 [TBL] [Abstract][Full Text] [Related]
20. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India. Gharai S; Venkatesh P; Garg S; Sharma SK; Vohra R Ophthalmic Epidemiol; 2008; 15(4):264-71. PubMed ID: 18780260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]